🔗 Share this article

Texas Attorney General Ken Paxton is suing the producers of Tylenol, alleging the companies withheld alleged dangers that the medication posed to pediatric brain development.

This legal action follows a month after President Donald Trump promoted an unverified association between using acetaminophen - alternatively called acetaminophen - during pregnancy and autism in offspring.

The attorney general is taking legal action against J&J, which formerly manufactured the drug, the only pain reliever suggested for expectant mothers, and the current manufacturer, which currently produces it.

In a statement, he stated they "deceived the public by gaining financially from pain and pushing pills ignoring the dangers."

Kenvue says there is insufficient reliable data connecting Tylenol to autism.

"These manufacturers lied for decades, deliberately risking millions to boost earnings," Paxton, a Republican, stated.

The company commented that it was "seriously troubled by the dissemination of inaccurate information on the security of paracetamol and the possible consequences that could have on the well-being of US mothers and children."

On its website, the company also stated it had "continuously evaluated the applicable studies and there is no credible data that shows a verified association between using acetaminophen and autism."

Associations representing physicians and health professionals agree.

ACOG has said paracetamol - the main ingredient in Tylenol - is one of the few options for women during pregnancy to treat discomfort and elevated temperature, which can present major wellness concerns if ignored.

"In over twenty years of investigation on the utilization of paracetamol in pregnancy, not a single reputable study has conclusively proven that the use of acetaminophen in any period of pregnancy causes neurological conditions in children," the association said.

The lawsuit mentions latest statements from the Trump administration in asserting the medication is reportedly hazardous.

In recent weeks, Trump generated worry from health experts when he advised expectant mothers to "resist strongly" not to use Tylenol when sick.

The US Food and Drug Administration then published an announcement that medical professionals should consider limiting the usage of Tylenol, while also mentioning that "a proven link" between the drug and autism in minors has remains unverified.

The Health Department head Robert F Kennedy Jr, who oversees the Food and Drug Administration, had promised in spring to initiate "comprehensive study program" that would establish the origin of autism spectrum disorder in a matter of months.

But specialists advised that discovering a unique factor of autism - thought by researchers to be the consequence of a intricate combination of inherited and surrounding conditions - would not be simple.

Autism is a form of lifelong neurodivergence and disability that affects how persons experience and engage with the surroundings, and is recognized using physician assessments.

In his legal document, Paxton - who supports Trump who is campaigning for federal office - alleges Kenvue and Johnson & Johnson "intentionally overlooked and attempted to silence the science" around acetaminophen and autism spectrum disorder.

The lawsuit seeks to make the companies "remove any marketing or advertising" that claims Tylenol is reliable for women during pregnancy.

The Texas lawsuit echoes the grievances of a collection of guardians of children with autism spectrum disorder and attention deficit hyperactivity disorder who sued the makers of acetaminophen in two years ago.

A federal judge threw out the legal action, saying research from the parents' expert witnesses was inconclusive.